141 related articles for article (PubMed ID: 35116558)
21. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
[No Abstract] [Full Text] [Related]
22. Prognostic Impact of Tumor Spread Through Air Spaces in Sublobar Resection for 1A Lung Adenocarcinoma Patients.
Ren Y; Xie H; Dai C; She Y; Su H; Xie D; Zheng H; Zhang L; Jiang G; Wu C; Chen C
Ann Surg Oncol; 2019 Jun; 26(6):1901-1908. PubMed ID: 30887374
[TBL] [Abstract][Full Text] [Related]
23. Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resection.
Toyokawa G; Yamada Y; Tagawa T; Oda Y
Thorac Cancer; 2018 Oct; 9(10):1255-1261. PubMed ID: 30079987
[TBL] [Abstract][Full Text] [Related]
24. Spread through air spaces predicts a worse survival in patients with stage I adenocarcinomas >2 cm after radical lobectomy.
Yang L; Yang Y; Ma P; Zheng B; Liu W; Zhang Z; Ding N; Liu L; Mao Y; Lv N
J Thorac Dis; 2018 Sep; 10(9):5308-5317. PubMed ID: 30416778
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of spread through air spaces in invasive mucinous lung adenocarcinoma after curative surgery.
Lee J; Cho S; Chung JH; Yoon SH; Shih BC; Jung W; Jeon JH; Kim K; Jheon S
Eur J Surg Oncol; 2024 Apr; 50(4):108053. PubMed ID: 38412587
[TBL] [Abstract][Full Text] [Related]
26. Semiquantitative Assessment of Tumor Spread through Air Spaces (STAS) in Early-Stage Lung Adenocarcinomas.
Uruga H; Fujii T; Fujimori S; Kohno T; Kishi K
J Thorac Oncol; 2017 Jul; 12(7):1046-1051. PubMed ID: 28363628
[TBL] [Abstract][Full Text] [Related]
27. Significance of Spread Through Air Spaces in Resected Lung Adenocarcinomas With Lymph Node Metastasis.
Toyokawa G; Yamada Y; Tagawa T; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Takamori S; Akamine T; Hirai F; Oda Y; Maehara Y
Clin Lung Cancer; 2018 Sep; 19(5):395-400.e1. PubMed ID: 29735272
[TBL] [Abstract][Full Text] [Related]
28. Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying Mechanism.
Xie H; Su H; Zhu E; Gu C; Zhao S; She Y; Ren Y; Xie D; Zheng H; Wu C; Dai C; Chen C
Front Oncol; 2021; 11():608353. PubMed ID: 33747923
[TBL] [Abstract][Full Text] [Related]
29. Characterization of lung adenocarcinoma with a cribriform component reveals its association with spread through air spaces and poor outcomes.
Ding Q; Chen D; Wang X; Wen J; Chen C; Zhang Y; Xu Z; Chen Y
Lung Cancer; 2019 Aug; 134():238-244. PubMed ID: 31319987
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection.
Chae M; Jeon JH; Chung JH; Lee SY; Hwang WJ; Jung W; Hwang Y; Cho S; Kim K; Jheon S
Lung Cancer; 2021 Feb; 152():21-26. PubMed ID: 33338924
[TBL] [Abstract][Full Text] [Related]
31. Tumor Spread Through Air Spaces Is an Independent Predictor of Recurrence-free Survival in Patients With Resected Lung Squamous Cell Carcinoma.
Kadota K; Kushida Y; Katsuki N; Ishikawa R; Ibuki E; Motoyama M; Nii K; Yokomise H; Bandoh S; Haba R
Am J Surg Pathol; 2017 Aug; 41(8):1077-1086. PubMed ID: 28498282
[TBL] [Abstract][Full Text] [Related]
32. Histopathologic features from preoperative biopsies to predict spread through air spaces in early-stage lung adenocarcinoma: a retrospective study.
Cao L; Jia M; Sun PL; Gao H
BMC Cancer; 2021 Aug; 21(1):913. PubMed ID: 34380457
[TBL] [Abstract][Full Text] [Related]
33. Spread through air spaces is an independent predictor of recurrence in stage III (N2) lung adenocarcinoma.
Terada Y; Takahashi T; Morita S; Kashiwabara K; Nagayama K; Nitadori JI; Anraku M; Sato M; Shinozaki-Ushiku A; Nakajima J
Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):442-448. PubMed ID: 31106332
[TBL] [Abstract][Full Text] [Related]
34. Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors.
Lee MA; Kang J; Lee HY; Kim W; Shon I; Hwang NY; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
Thorac Cancer; 2020 Nov; 11(11):3145-3154. PubMed ID: 32975379
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.
Li M; Yang X; Chen Y; Yang X; Dai X; Sun F; Zhang L; Zhan C; Feng M; Wang Q
Onco Targets Ther; 2017; 10():2885-2892. PubMed ID: 28652770
[TBL] [Abstract][Full Text] [Related]
36. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.
Qiu X; Chen D; Liu Y; Duan S; Zhang F; Zhang Y; Li F; Chen C; Chen Y
Thorac Cancer; 2019 Feb; 10(2):256-267. PubMed ID: 30605235
[TBL] [Abstract][Full Text] [Related]
37. Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for Stratifying Patients Who Might Be Eligible for Lung Sparing Surgery for Stage I Adenocarcinomas.
Zombori T; Sejben A; Tiszlavicz L; Cserni G; Pálföldi R; Csada E; Furák J
Pathol Oncol Res; 2020 Oct; 26(4):2451-2458. PubMed ID: 32564261
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological Impact of the Spread through Air Space in Non-Small Cell Lung Cancer: A Meta-Analysis.
Pyo JS; Kim NY
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626268
[TBL] [Abstract][Full Text] [Related]
39. Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.
Kang YK; Song YS; Cho S; Jheon S; Lee WW; Kim K; Kim SE
Lung Cancer; 2018 May; 119():1-6. PubMed ID: 29656743
[TBL] [Abstract][Full Text] [Related]
40. Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis.
Chen C; Ni Q; Shi Y; Fu S; Pan X; Wang Y; Yang J; Wang R
Transl Cancer Res; 2019 Apr; 8(2):574-582. PubMed ID: 35116790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
